Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Author： Daneshpour Nooshin   Griffin Martin   Collighan Russell   Perrie Yvonne  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.19, Iss.8, 2011-09, pp. : 624-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing strategies for liver fibrosis treatment

By Murphy Frank   Arthur Michael   Iredale John  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

The Significance of COX-2 and COX-2 Inhibitors in Liver Fibrosis and Liver Cancer

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 2, 2005-01 ,pp. : 199-206

Bentham Science Publishers

Access to resources Recommend Favorite

Significance of Hepatoprotective Liver Specific Targeted Drug Delivery: A Review on Novel Herbal and Formulation Approaches in the Management of Hepatotoxicity

By  

Current Drug Targets, Vol. 19, Iss. 13, 2018-10 ,pp. : 1519-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs

By  

Current Molecular Pharmacology, Vol. 1, Iss. 1, 2008-01 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomes as targeted drug delivery systems in the treatment of breast cancer

By Sharma G.   Anabousi S.   Ehrhardt C.   Ravi Kumar M. N. V.  

Journal of Drug Targeting, Vol. 14, Iss. 5, 2006-06 ,pp. : 301-310

Informa Healthcare

Access to resources Recommend Favorite